Breaking News

GSK Uses Capsugel’s Licaps

Reduces product lead times by 12 weeks

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Capsugel’s Licaps liquid-filled hard capsules have been successfully used by GlaxoSmithKline for GRANU FINK, an established product line in the German urological market.   The product was initially launched in a soft gelatin capsule form and GSK decided to investigate other dosage form options to improve the product’s quality and reduce its production-to-market lead time. GRANU FINK’s active ingredients, pumpkin seeds extracts and pumpkin oil, were challenging to encapsulate because of the large...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters